Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart-Assist Devices | 11 | 2024 | 1195 | 1.670 |
Why?
|
Heart Failure | 14 | 2024 | 10896 | 0.930 |
Why?
|
Shock, Cardiogenic | 3 | 2023 | 688 | 0.800 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 2 | 2022 | 236 | 0.700 |
Why?
|
Correspondence as Topic | 1 | 2018 | 27 | 0.630 |
Why?
|
Auscultation | 1 | 2017 | 42 | 0.590 |
Why?
|
Stethoscopes | 1 | 2017 | 29 | 0.580 |
Why?
|
Nephrolithiasis | 1 | 2018 | 110 | 0.560 |
Why?
|
Pulsatile Flow | 1 | 2017 | 332 | 0.560 |
Why?
|
Aortic Diseases | 1 | 2022 | 743 | 0.550 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2023 | 1354 | 0.510 |
Why?
|
Heart Rate | 3 | 2023 | 4091 | 0.470 |
Why?
|
Respiratory Sounds | 1 | 2017 | 696 | 0.430 |
Why?
|
Speech | 1 | 2017 | 541 | 0.410 |
Why?
|
Blood Pressure | 4 | 2023 | 8551 | 0.290 |
Why?
|
Hypercholesterolemia | 2 | 2023 | 1151 | 0.280 |
Why?
|
Ventricular Function, Left | 2 | 2021 | 3660 | 0.260 |
Why?
|
Coronary Artery Disease | 2 | 2022 | 6485 | 0.260 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2023 | 3255 | 0.230 |
Why?
|
Hypertension | 3 | 2018 | 8480 | 0.220 |
Why?
|
Primary Graft Dysfunction | 1 | 2023 | 93 | 0.220 |
Why?
|
Seed Storage Proteins | 1 | 2022 | 12 | 0.210 |
Why?
|
Germination | 1 | 2022 | 12 | 0.210 |
Why?
|
Hyperemia | 1 | 2023 | 225 | 0.210 |
Why?
|
Bed Occupancy | 1 | 2022 | 41 | 0.210 |
Why?
|
Heart Failure, Systolic | 1 | 2023 | 126 | 0.210 |
Why?
|
Myocardial Infarction | 1 | 2023 | 11708 | 0.210 |
Why?
|
Seeds | 1 | 2022 | 105 | 0.200 |
Why?
|
Pandemics | 1 | 2022 | 8385 | 0.200 |
Why?
|
Hemodynamics | 2 | 2023 | 4197 | 0.180 |
Why?
|
Hospital Mortality | 3 | 2022 | 5316 | 0.170 |
Why?
|
History, 17th Century | 1 | 2018 | 111 | 0.160 |
Why?
|
von Willebrand Factor | 1 | 2021 | 669 | 0.150 |
Why?
|
Humans | 33 | 2024 | 743811 | 0.140 |
Why?
|
Dyssomnias | 1 | 2016 | 29 | 0.140 |
Why?
|
Cardiovascular Diseases | 1 | 2022 | 15142 | 0.140 |
Why?
|
Retrospective Studies | 11 | 2023 | 77410 | 0.140 |
Why?
|
Cholesterol, LDL | 2 | 2023 | 2354 | 0.140 |
Why?
|
Aorta, Thoracic | 1 | 2022 | 1084 | 0.130 |
Why?
|
Sleep Apnea, Obstructive | 2 | 2021 | 1813 | 0.130 |
Why?
|
Blood Pressure Determination | 1 | 2018 | 633 | 0.120 |
Why?
|
Renal Replacement Therapy | 1 | 2016 | 258 | 0.120 |
Why?
|
Hemolysis | 1 | 2016 | 420 | 0.120 |
Why?
|
History, 19th Century | 1 | 2017 | 720 | 0.120 |
Why?
|
Proteinuria | 1 | 2016 | 658 | 0.120 |
Why?
|
Thrombosis | 2 | 2018 | 2968 | 0.110 |
Why?
|
Risk Factors | 10 | 2023 | 72252 | 0.110 |
Why?
|
Dyslipidemias | 1 | 2020 | 851 | 0.110 |
Why?
|
Endothelium, Vascular | 2 | 2016 | 4459 | 0.110 |
Why?
|
Middle Aged | 12 | 2023 | 213241 | 0.100 |
Why?
|
Mitral Valve Insufficiency | 1 | 2021 | 1421 | 0.100 |
Why?
|
Angiopoietin-2 | 2 | 2023 | 172 | 0.100 |
Why?
|
Endocytosis | 1 | 2016 | 985 | 0.100 |
Why?
|
Endothelial Cells | 3 | 2023 | 3482 | 0.100 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2021 | 2074 | 0.090 |
Why?
|
Renal Insufficiency | 1 | 2016 | 805 | 0.090 |
Why?
|
Hemoglobins | 1 | 2016 | 1531 | 0.090 |
Why?
|
Heart Ventricles | 1 | 2022 | 3817 | 0.090 |
Why?
|
Inpatients | 1 | 2022 | 2515 | 0.090 |
Why?
|
Heart Transplantation | 1 | 2023 | 3113 | 0.090 |
Why?
|
Phenotype | 3 | 2023 | 16361 | 0.090 |
Why?
|
Peptides | 1 | 2022 | 4406 | 0.090 |
Why?
|
Patient Readmission | 1 | 2023 | 3117 | 0.090 |
Why?
|
Tobacco Smoke Pollution | 1 | 2015 | 816 | 0.080 |
Why?
|
Male | 14 | 2023 | 349776 | 0.080 |
Why?
|
Calcium | 1 | 2022 | 5755 | 0.080 |
Why?
|
Glomerular Filtration Rate | 1 | 2016 | 2167 | 0.080 |
Why?
|
Intensive Care Units | 1 | 2022 | 3679 | 0.080 |
Why?
|
Arteries | 1 | 2013 | 1119 | 0.080 |
Why?
|
Hospitals | 1 | 2022 | 3953 | 0.080 |
Why?
|
Warfarin | 1 | 2016 | 1497 | 0.080 |
Why?
|
Ambulatory Care | 1 | 2018 | 2707 | 0.080 |
Why?
|
Atherosclerosis | 1 | 2023 | 3445 | 0.070 |
Why?
|
Pericardium | 2 | 2021 | 667 | 0.070 |
Why?
|
New York | 2 | 2020 | 885 | 0.070 |
Why?
|
Female | 13 | 2023 | 380020 | 0.070 |
Why?
|
Stroke | 2 | 2018 | 9975 | 0.060 |
Why?
|
Prosthesis Design | 2 | 2023 | 2103 | 0.060 |
Why?
|
Risk Assessment | 2 | 2022 | 23327 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2021 | 5033 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2023 | 20121 | 0.050 |
Why?
|
Adult | 6 | 2023 | 213889 | 0.050 |
Why?
|
Intra-Aortic Balloon Pumping | 1 | 2023 | 219 | 0.050 |
Why?
|
Chromatography | 1 | 2022 | 206 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5752 | 0.050 |
Why?
|
Electrophoresis | 1 | 2022 | 240 | 0.050 |
Why?
|
Endothelin-1 | 1 | 2023 | 314 | 0.050 |
Why?
|
Middle Cerebral Artery | 1 | 2023 | 264 | 0.050 |
Why?
|
Weibel-Palade Bodies | 1 | 2021 | 19 | 0.050 |
Why?
|
Anticoagulants | 1 | 2016 | 4599 | 0.050 |
Why?
|
Inflammation | 2 | 2023 | 10629 | 0.050 |
Why?
|
Aged | 6 | 2023 | 163178 | 0.050 |
Why?
|
Stroke Volume | 2 | 2023 | 5002 | 0.040 |
Why?
|
Adipose Tissue | 2 | 2021 | 3280 | 0.040 |
Why?
|
Cohort Studies | 1 | 2022 | 40545 | 0.040 |
Why?
|
Oxidative Stress | 2 | 2023 | 3082 | 0.040 |
Why?
|
Microcirculation | 1 | 2023 | 1287 | 0.040 |
Why?
|
Smoking | 1 | 2015 | 8984 | 0.040 |
Why?
|
Urofollitropin | 1 | 2016 | 2 | 0.040 |
Why?
|
Cholesterol, HDL | 1 | 2023 | 1813 | 0.040 |
Why?
|
Complement Membrane Attack Complex | 1 | 2016 | 112 | 0.030 |
Why?
|
Aftercare | 1 | 2021 | 870 | 0.030 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2016 | 424 | 0.030 |
Why?
|
International Normalized Ratio | 1 | 2016 | 367 | 0.030 |
Why?
|
Cotinine | 1 | 2015 | 206 | 0.030 |
Why?
|
Preoperative Period | 1 | 2016 | 550 | 0.030 |
Why?
|
Urinalysis | 1 | 2016 | 369 | 0.030 |
Why?
|
Equipment Failure | 1 | 2016 | 578 | 0.030 |
Why?
|
Brachial Artery | 1 | 2015 | 369 | 0.030 |
Why?
|
Survival Rate | 2 | 2018 | 12786 | 0.030 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2015 | 689 | 0.030 |
Why?
|
Biological Transport | 1 | 2016 | 2119 | 0.020 |
Why?
|
Vasodilation | 1 | 2015 | 944 | 0.020 |
Why?
|
Tyrosine | 1 | 2015 | 1462 | 0.020 |
Why?
|
Incidence | 2 | 2021 | 20948 | 0.020 |
Why?
|
Blood Coagulation | 1 | 2016 | 1127 | 0.020 |
Why?
|
Coronary Vessels | 1 | 2021 | 3106 | 0.020 |
Why?
|
Prognosis | 2 | 2020 | 29052 | 0.020 |
Why?
|
Patient Discharge | 1 | 2021 | 3317 | 0.020 |
Why?
|
ROC Curve | 1 | 2016 | 3527 | 0.020 |
Why?
|
Computer Simulation | 1 | 2022 | 6188 | 0.020 |
Why?
|
Registries | 1 | 2024 | 8090 | 0.020 |
Why?
|
Sleep Apnea Syndromes | 1 | 2016 | 944 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2016 | 21733 | 0.020 |
Why?
|
Models, Statistical | 1 | 2022 | 5100 | 0.020 |
Why?
|
HIV Infections | 1 | 2013 | 16715 | 0.020 |
Why?
|
Cholesterol | 1 | 2016 | 2922 | 0.020 |
Why?
|
NF-kappa B | 1 | 2015 | 2500 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2016 | 4326 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6539 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15067 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2021 | 19232 | 0.020 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2013 | 1872 | 0.020 |
Why?
|
Hemorrhage | 1 | 2016 | 3458 | 0.020 |
Why?
|
Genotype | 1 | 2016 | 12944 | 0.010 |
Why?
|
Electrocardiography | 1 | 2013 | 6441 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 40038 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2016 | 7880 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2016 | 19894 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 15211 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 57744 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2021 | 63042 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 25032 | 0.010 |
Why?
|
Young Adult | 1 | 2015 | 56392 | 0.010 |
Why?
|
Concepts
(144)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(9)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_